Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial

被引：1
|
作者：
Kindler, H
Lu, C
Gandara, D
Stevenson, J
Krug, L
Janne, P
Gitlitz, B
Karrison, T
Stadler, W
Vokes, E
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Univ So Calif, Los Angeles, CA USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80210-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [1] Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
    Kindler, Hedy L.
    Karrison, Theodore G.
    Gandara, David R.
    Lu, Charles
    Krug, Lee M.
    Stevenson, James P.
    Jaenne, Pasi A.
    Quinn, David I.
    Koczywas, Marianna N.
    Brahmer, Julie R.
    Albain, Kathy S.
    Taber, David A.
    Armato, Samuel G., III
    Vogelzang, Nicholas J.
    Chen, Helen X.
    Stadler, Walter M.
    Vokes, Everett E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2509 - 2515
  • [2] Final analysis of a multi-center, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo (P) in patients with malignant mesothelioma
    Kindler, Hedy L.
    Karrison, Theodore
    Gandara, David R.
    Lu, Charles
    Guterz, Tamara L.
    Nichols, Katharine
    Chen, Helen
    Stadler, Walter M.
    Vokes, Everett E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S374 - S374
  • [3] Final analysis of a multi-center, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo (P) in patients (pts) with malignant mesothelioma (MM)
    Karrison, T.
    Kindler, H. L.
    Gandara, D. R.
    Lu, C.
    Guterz, T. L.
    Nichols, K.
    Chen, H.
    Stadler, W. M.
    Vokes, E. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM).
    Kindler, HL
    Karrison, T
    Lu, C
    Gandara, DR
    Stevenson, J
    Krug, L
    Janne, P
    Guterz, TL
    Stadler, WM
    Vokes, EE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 625S - 625S
  • [5] Parenteral hydration (PH) in advanced cancer patients: A multi-center, double-blind, placebo-controlled randomized trial
    Dalal, Shalini
    Hui, David
    Torres-Vigil, Isabel
    Palmer, J. Lynn
    Allo, Julio
    Frisbee-Hume, Susan
    Tarleton, Kenneth
    Bruera, Eduardo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Chinese Herbs For Acute Asthma: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
    Wang, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC)
    Kang, Y.
    Ohtsu, A.
    Van Cutsem, E.
    Rha, S. Y.
    Sawaki, A.
    Park, S.
    Lim, H.
    Wu, J.
    Langer, B.
    Shah, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [8] PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
    Kitson, Sarah J.
    Maskell, Zoe
    Sivalingam, Vanitha N.
    Allen, Jennifer L.
    Ali, Saad
    Burns, Sean
    Gilmour, Kyle
    Latheef, Rahamatulla
    Slade, Richard J.
    Pemberton, Philip W.
    Shaw, Joseph
    Ryder, W. David
    Kitchener, Henry C.
    Crosbie, Emma J.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2424 - 2432
  • [9] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
    Wermuth, L
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
  • [10] Efficacy of Huadananshen mistura on insomnia: a randomized, double-blind, placebo-controlled, and multi-center clinical trial
    Huafang Li
    Xiaoli Yan
    Ting Li
    Jian Xu
    Qiaochu Wang
    Yifeng Xu
    [J]. Journal of Traditional Chinese Medicine, 2013, 33 (04) : 423 - 427
12345